Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Iron Isomaltoside in the Treatment of Peritoneal Dialysis Patients with Renal Related Anemia: a Randomized Controlled Trial

NCT06830941 is registered in ClinicalTrials.gov with Xie Jingyuan, MD as lead sponsor.

NCT NCT06830941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06830941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Iron Isomaltoside in the Treatment of Peritoneal Dialysis Patients with Renal Related Anemia: a Randomized Controlled Trial
Lead sponsor
Xie Jingyuan, MD
Phase
Phase 4
Overall status
Not yet recruiting
Start date
February 15, 2025
Completion date
December 31, 2027
Enrollment
124 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peritoneal dialysis (pd), renal anemia